R
Roger McIntyre
Professor of Psychiatry and Pharmacology at the University of Toronto
Key Impact
A global leader in mood disorder research and a pioneer in rapid-acting treatments like ketamine.
Background & Research
Roger McIntyre is one of the world's most cited researchers in the field of depression and bipolar disorder. Head of the Mood Disorders Psychopharmacology Unit at UHN, he has been instrumental in the clinical implementation of ketamine for treatment-resistant depression. He leads multiple international initiatives to improve brain health and psychiatric care through innovative pharmacological and psychedelic research.
Focus Areas
Mood DisordersKetamineBrain HealthPsychopharmacology